MX2010010795A - Uso de defensinas contra meningitis. - Google Patents

Uso de defensinas contra meningitis.

Info

Publication number
MX2010010795A
MX2010010795A MX2010010795A MX2010010795A MX2010010795A MX 2010010795 A MX2010010795 A MX 2010010795A MX 2010010795 A MX2010010795 A MX 2010010795A MX 2010010795 A MX2010010795 A MX 2010010795A MX 2010010795 A MX2010010795 A MX 2010010795A
Authority
MX
Mexico
Prior art keywords
polypeptide
meningitis
polypeptides
defensin
amino acid
Prior art date
Application number
MX2010010795A
Other languages
English (en)
Spanish (es)
Inventor
Dorthe Sandvang
Hans-Henrik Kristensen Hoegenhaug
Original Assignee
Novozymes Adenium Biotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40875112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010010795(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novozymes Adenium Biotech As filed Critical Novozymes Adenium Biotech As
Publication of MX2010010795A publication Critical patent/MX2010010795A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729Cationic antimicrobial peptides, e.g. defensins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723Cationic antimicrobial peptides, e.g. defensins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MX2010010795A 2008-04-04 2009-03-30 Uso de defensinas contra meningitis. MX2010010795A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154103 2008-04-04
PCT/EP2009/053726 WO2009121828A1 (en) 2008-04-04 2009-03-30 Use of defensins against meningitis

Publications (1)

Publication Number Publication Date
MX2010010795A true MX2010010795A (es) 2011-01-12

Family

ID=40875112

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010010795A MX2010010795A (es) 2008-04-04 2009-03-30 Uso de defensinas contra meningitis.

Country Status (18)

Country Link
US (1) US20090253629A1 (pt)
EP (1) EP2278991A1 (pt)
JP (1) JP2011516450A (pt)
KR (1) KR20100134025A (pt)
CN (1) CN102036678A (pt)
AP (1) AP2010005403A0 (pt)
AR (1) AR071177A1 (pt)
AU (1) AU2009231463A1 (pt)
BR (1) BRPI0909021A2 (pt)
CA (1) CA2720380A1 (pt)
CL (1) CL2009000811A1 (pt)
EA (1) EA201071163A1 (pt)
IL (1) IL208189A0 (pt)
MX (1) MX2010010795A (pt)
PE (1) PE20091781A1 (pt)
TW (1) TW200942254A (pt)
WO (1) WO2009121828A1 (pt)
ZA (1) ZA201006645B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201028154A (en) * 2008-10-23 2010-08-01 Novozymes As Antibiotic synergism
TW201125577A (en) * 2009-12-02 2011-08-01 Novozymes As Use of defensins for treatment of infective endocarditis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US20040265337A1 (en) * 2002-08-21 2004-12-30 Zsebo Krisztina M. Method of generating an immune response and compositions used for same
MX2007005520A (es) * 2004-11-12 2007-07-09 Novozymes As Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que codifican los mismos.
EP1850861A1 (en) * 2005-02-08 2007-11-07 Novozymes A/S Systemic treatment of infections with defensins
AU2006256791B2 (en) * 2005-06-06 2012-01-19 Novozymes Adenium Biotech A/S Polypeptides having antimicrobial activity and polynucleotides encoding same

Also Published As

Publication number Publication date
AP2010005403A0 (en) 2010-10-31
WO2009121828A1 (en) 2009-10-08
ZA201006645B (en) 2011-06-29
EP2278991A1 (en) 2011-02-02
CA2720380A1 (en) 2009-10-08
AR071177A1 (es) 2010-06-02
BRPI0909021A2 (pt) 2015-09-22
JP2011516450A (ja) 2011-05-26
US20090253629A1 (en) 2009-10-08
IL208189A0 (en) 2010-12-30
PE20091781A1 (es) 2009-12-03
KR20100134025A (ko) 2010-12-22
EA201071163A1 (ru) 2011-04-29
TW200942254A (en) 2009-10-16
CL2009000811A1 (es) 2010-05-07
CN102036678A (zh) 2011-04-27
AU2009231463A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
CN101155825B (zh) 抗微生物六肽
US6071879A (en) Method for the treatment of bacterial infection
JP2009521932A (ja) 抗菌性カテリシジンペプチド
CN103764669B (zh) 抗炎药物产品
US7745390B2 (en) Antimicrobial peptides
KR102415734B1 (ko) 신규한 항균 펩타이드 및 이의 용도
JP5208135B2 (ja) 組換え白血球阻害因子とヒルゲンのキメラタンパク質及びその薬物組成物
JP4932731B2 (ja) シグナルペプチド、核酸分子及び治療方法
CA2388910C (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
JP2000511424A (ja) ラクトフェリン変異体およびその使用
US20150018268A1 (en) Multivalent synthetic compounds as antibiotic treatment
MX2010010795A (es) Uso de defensinas contra meningitis.
CN112194730B (zh) 一种多肽ti-16及其用途
CN102264383A (zh) 胞内细菌感染的处理
KR101624691B1 (ko) 신규한 세크로핀 유사 항진균 펩타이드 및 그의 조성물
US8653024B2 (en) Use of AMPs for treatment of UTI/cystitis
US20240254175A1 (en) Novel selective antimicrobial fusion peptides
KR20230163124A (ko) 코로나바이러스 질환의 예방 또는 치료용 조성물
AU2020204461A1 (en) A method of in vivo treatment
KR20210154308A (ko) 아메리카왕거저리 유충으로부터 유래된 펩타이드인 조포바신-1 및 이의 용도
CN118767111A (zh) 一种抗耐药菌活性肽Hydrostatin-AMP3在治疗细菌性脓毒症中的应用
JP2002114704A (ja) 抗菌剤
WO2009074133A2 (de) C-terminale ifapsoriasinfragmente als antimikrobielle peptide, deren herstellung und verwendung
US20110130326A1 (en) Defensins for treatment of infective endocarditis

Legal Events

Date Code Title Description
FA Abandonment or withdrawal